Covalent and noncovalent interactions mediate metabotropic glutamate receptor mGlu5 dimerization

被引:109
作者
Romano, C
Miller, JK
Hyrc, K
Dikranian, S
Mennerick, S
Takeuchi, Y
Goldberg, MP
O'Malley, KL
机构
[1] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
[4] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA
[5] Banyu Tsukaba Res Inst, Tsukuba, Ibaraki, Japan
关键词
D O I
10.1124/mol.59.1.46
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Some, perhaps all, G protein-coupled receptors form homo- or heterodimers. We have shown that metabotropic glutamate receptors are covalent dimers, held together by one or more disulfide bonds near the N terminus. Here we report how mutating cysteines in this region affect dimerization and function. Covalent dimerization is preserved when cysteines 57, 93, or 99 are mutated but lost with replacement at 129. Coimmunoprecipitation under nondenaturing conditions indicates that the C[129]S mutant receptor remains a dimer, via noncovalent interactions. Both C[93]S and C[129]S bind [H-3] quisqualate, whereas binding to C[57]S or C[99]S mutants is absent or greatly attenuated. The C[93]S and C[129]S receptors have activity similar to wild-type when assayed by fura-2 imaging of intracellular calcium in human embryonic kidney cells or electrophysiologically in Xenopus laevis oocytes. In contrast, C[57]S or C[99]S are less active in both assays but do respond with higher glutamate concentrations in the oocyte assay. These results demonstrate that 1) covalent dimerization is not critical for mGlu(5) binding or function; 2) mGlu(5) remains a noncovalent dimer even in the absence of covalent dimerization; and 3) high-affinity binding requires Cys-57 and Cys-99.
引用
收藏
页码:46 / 53
页数:8
相关论文
共 32 条
  • [1] Involvement of the amino terminus of the B2 receptor in agonist-induced receptor dimerization
    AbdAlla, S
    Zaki, E
    Lother, H
    Quitterer, U
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (37) : 26079 - 26084
  • [2] OLIGOMERIC STRUCTURE OF MUSCARINIC RECEPTORS IS SHOWN BY PHOTOAFFINITY-LABELING - SUBUNIT ASSEMBLY MAY EXPLAIN HIGH-AFFINITY AND LOW-AFFINITY AGONIST STATES
    AVISSAR, S
    AMITAI, G
    SOKOLOVSKY, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (01): : 156 - 159
  • [3] Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells
    Bai, M
    Trivedi, S
    Brown, EM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (36) : 23605 - 23610
  • [4] The agonist-binding domain of the calcium-sensing receptor is located at the amino-terminal domain
    Bräuner-Osborne, H
    Jensen, AA
    Sheppard, PO
    O'Hara, P
    Krogsgaard-Larsen, P
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (26) : 18382 - 18386
  • [5] INVESTIGATION OF THE ORGANIZATION OF RHODOPSIN IN THE SHEEP PHOTORECEPTOR MEMBRANE BY USING CROSS-LINKING REAGENTS
    BRETT, M
    FINDLAY, JBC
    [J]. BIOCHEMICAL JOURNAL, 1979, 177 (01) : 215 - 223
  • [6] Dimerization of the delta opioid receptor: Implication for a role in receptor internalization
    Cvejic, S
    Devi, LA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (43) : 26959 - 26964
  • [7] Mutagenesis and modeling of the GABAB receptor extracellular domain support a Venus flytrap mechanism for ligand binding
    Galvez, T
    Parmentier, ML
    Joly, C
    Malitschek, B
    Kaupmann, K
    Kuhn, R
    Bittiger, H
    Froestl, W
    Bettler, B
    Pin, JP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (19) : 13362 - 13369
  • [8] Gomeza J, 1996, MOL PHARMACOL, V50, P923
  • [9] GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440
  • [10] Ligand binding to the amino-terminal domain of the mGluR4 subtype of metabotropic glutamate receptor
    Han, GM
    Hampson, DR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (15) : 10008 - 10013